Gain Therapeutics Inc (GANX)

Gain Therapeutics Inc (GANX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $71.6M; returns 1 day -2.3%, 1 week +0.0%, 1 year -36.0%.

Gain Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of next-generation allosteric small molecule therapies for neurodegenerative and rare genetic diseases. The company currently generates no revenue from product sales, as its entire pipeline is in development.

Groups GANX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Drug Discovery
• Neuroscience
• Rare Diseases
• CNS Disorders
• Artificial Intelligence
• Life Sciences
• Clinical Stage
• Small Business Lending
• AI in Healthcare

GANX financial model: income statement, cash flow and balance sheet